A breakthrough new drug CBL0137 has proven effective in mice treated with chemotherapy and is being tested as a potential treatment for all types of cancer, including solid tumours. The drug works by reactivating the body's P53 pathway to kill off damaged cells.
SourceChildren's Cancer Institute Australia·JournalInternational Journal of Cancer·DateJul 27, 2019
A new study found that 5- to 8-month-old babies exhibit face-specific brain activity in response to yawning, suggesting a neural basis for their preference. The research used functional near-infrared spectroscopy (fNIRS) to measure brain activity while babies viewed yawning and mouth movement.
SourceChuo University·JournalScientific Reports·DateJul 27, 2019